Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

High-content imaging zur Identifikation von Replikationsfehlern


Dysregulation of DNA-licensing is a hallmark for hereditary diseases, as well as for the development of tumour cells. Here we show how the combination of high-content imaging (HCl) with highly specific antibodies from Proteintech allows deeper insights into the timing of replication licensing following the loading of specific markers onto the DNA. Similar to flow cytometry, HCl can be used to investigate large quantities of cells whilst adding crucial structural information.

This is a preview of subscription content, log in to check access.


  1. [1]

    Chessel A, Carazo Salas RE (2019) From observing to predicting single-cell structure and function with high-through-put/high-ontent microscopy. Essays Biochem 63:197–208

  2. [2]

    Thomas N (2010) High-content screening: a decade of evolution. J Biomol Screen 15:1–9

  3. [3]

    Pegoraro G, Misteli T (2017) High-throughput imaging for the discovery of cellular mechanisms of disease. Trends Genet 33:604–615

  4. [4]

    Blow JJ (2019) Defects in the origin licensing checkpoint stresses cells exiting GO. J Cell Biol 218:2080–2081

  5. [5]

    Jackson AP, Laskey RA, Coleman N (2014) Replication proteins and human disease. Cold Spring Harb Perspect Biol 6, doi:

Download references

Author information

Correspondence to Dr. Karolina Szczesna or Dr. Viola Denninger.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Szczesna, K., Denninger, V. High-content imaging zur Identifikation von Replikationsfehlern. Biospektrum 26, 66–68 (2020).

Download citation